medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 1

<< Back Next >>

salud publica mex 2020; 62 (1)

Population impact of rotavirus vaccination in Mexico after 10 years

Richardson-López CV, Bautista-Márquez A, Sánchez-Uribe E, Esparza-Aguilar M

Language: Spanish
References: 25
Page: 6-13
PDF size: 431.05 Kb.


ABSTRACT

Objective. To evaluate the impact of rotavirus (RV) vaccination after 10 years of it´s universalization on morbidity and mortality from Acute Diarrheal Disease (ADD) in mexican children under five years of age. Materials and methods. Annual median numbers for ADD new cases, hospitalizations and deaths were compared between pre and post universalization periods; absolute and relative reductions were calculated, considering p‹0.05 values as significant. Results. Mortality, hospitalizations and new cases from ADD in children under five decreased 52.6, 46, and 15.5% respectively, in the posuniversalization period. During rotavirus seasons, reduction in mortality, hospitalizations and new cases was 66.9, 64.7, and 28.7% respectively. Conclusions. As of the universal introduction of RV vaccination in Mexico, significant and sustained reductions are appreciated for mortality and hospitalizations from ADD, less so for incidence. A most prominent effect is observed during the winter season.


REFERENCES

  1. Dirección General de Epidemiología, Secretaría de Salud. Sistema Único Automatizado para la Vigilancia Epidemiológica [internet]. México: SSA, 1995 [citado julio 9, 2018]. Disponible en: http://www.sinave.gob.mx/ SUAVE/Inicio_sesion.aspx

  2. Dirección General de Información en Salud, Secretaría de Salud. Subsistema Automatizado de Egresos Hospitalarios [Internet]. México: SSA, 2000 [citado junio 20, 2018]. Disponible en: http://www.dgis.salud.gob.mx/ contenidos/basesdedatos/bdc_egresoshosp_gobmx.html

  3. Cubo de Defunciones [Internet]. México: Dirección General de Información en Salud, Secretaría de Salud, 1979 [citado Jun 20, 2018]. Disponible: http://www.dgis.salud.gob.mx/contenidos/basesdedatos/ bdc_defunciones_gobmx.html

  4. Gutiérrez G, Tapia-Conyer R, Guiscafre H, Reyes H, Martínez H, Kumate J. Impact of oral rehydration and selected public health interventions on reduction of mortality from childhood diarrhoeal diseases in Mexico. Bull World Health Organ. 1996;74(2):189-97.

  5. Velázquez R, Calva JJ, Guerrero L, Mass D, Glass RI, Pickering LK, et al. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children. Pediatr Infect Dis J. 1993;12(1):54- 61. https://doi.org/10.1097/00006454-199301000-00013

  6. Villa S, Guiscafré H, Martínez H, Muñoz O, Gutiérrez G. Seasonal diarrhoeal mortality among Mexican children. Bull World Health Organ. 1999;77(5):375-80.

  7. Velázquez F, García-Lozano H, Rodríguez E, Cervantes Y, Gómez A, Melo M, et al. Diarrhea morbidity and mortality in Mexican children. Impact of Rotavirus Disease. Pediatr Infect Dis J. 2004;23:S149-55. https://doi. org/10.1097/01.inf.0000142463.72442.91

  8. Ruiz-Palacios GM, Pérez-Schael I, Velázquez R, Abate H, Breuer T, Costa-Clemens S, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. https://doi. org/10.1056/NEJMoa052434

  9. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine. N Engl J Med. 2006;354:23-33. https://doi. org/10.1056/NEJMoa052664

  10. Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ. 2009;87:535- 41. https://doi.org/10.2471/BLT.08.053819

  11. Dirección General de Información en Salud, Secretaría de Salud. Servicios otorgados [Internet]. México: SSA, 2000 - 2016 [citado julio 21, 2018]. Disponible en: http://www.dgis.salud.gob.mx/contenidos/basesdedatos/ bdc_serviciossis_gobmx.html

  12. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca: Instituto Nacional de Salud Pública, 2012.

  13. Díaz-Ortega JL, Ferreira-Guerrero E, Trejo-Valdivia B, Téllez-Rojo MM, Ferreyra-Reyes L, Hernández-Serrato M, et al. Cobertura de vacunación en niños y adolescentes en México: esquema completo, incompleto y no vacunación. Salud Publica Mex. 2013;55(supl 2):S289-99.

  14. Díaz-Ortega JL, Cruz-Hervert LC, Ferreira-Guerrero E, Ferreyra-Reyes LD, Delgado-Sánchez G, García-García ML. Cobertura de vacunación y proporción de esquema incompleto en niños menores de siete años en México. Salud Publica Mex. 2018;60:338-46. https://doi.org/10.21149/8812

  15. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza- Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362(4):299-305. https://doi.org/10.1056/NEJMoa0905211

  16. Sánchez-Uribe E, Esparza-Aguilar M, Parashar UD, Richardson V. Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization. Clin Infect Dis. 2016;62(suppl 2): S133-9. https://doi.org/10.1093/cid/civ1205

  17. Esparza-Aguilar M, Bautista-Márquez A, González-Andrade MC, Richardson-López-Collada VL. Mortalidad por enfermedad diarreica en menores, antes y después de la introducción de la vacuna contra el rotavirus. Salud Publica Mex. 2009;51:285-90. https://doi.org/10.1590/ S0036-36342009000400004

  18. Esparza-Aguilar M, Gastañaduy PA, Sánchez-Uribe E, Desai R, Parashar UD, Richardson V, et al. Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico. Bull World Health Organ. 2014;92:117-25. https://doi.org/10.2471/ BLT.13.125286

  19. Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009;124:465-71. https://doi. org/10.1542/peds.2008-3528

  20. Parashar UD, Glass RI. Rotavirus vaccines – early success, remaining questions. N Engl J Med. 2009;360:1063-5. https://doi.org/10.1056/NEJMp0810154

  21. GBD Diarrheal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(9):909-48. https://doi.org/10.1016/S1473- 3099(17)30276-1

  22. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209-22. https:// doi.org/10.1016/S0140-6736(13)60844-2

  23. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388:3027-35. https://doi.org/10.1016/S0140-6736(16)31593-8

  24. Lamberti LM, Ashraf S, Walker CL, Black RE. Systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years. Pediatr Infect Dis J. 2016;35(9):992-8. https://doi. org/10.1097/INF.0000000000001232

  25. Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666-72. https://doi.org/10.1093/infdis/ jix186




2020     |     www.medigraphic.com